» Articles » PMID: 15976140

Green Tea Polyphenol Epigallocatechin Gallate Inhibits Adipogenesis and Induces Apoptosis in 3T3-L1 Adipocytes

Overview
Journal Obes Res
Date 2005 Jun 25
PMID 15976140
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Green tea catechins have been shown to promote loss of body fat and to inhibit growth of many cancer cell types by inducing apoptosis. The objective of this study was to determine whether epigallocatechin gallate (EGCG), the primary green tea catechin, could act directly on adipocytes to inhibit adipogenesis and induce apoptosis.

Research Methods And Procedures: Mouse 3T3-L1 preadipocytes and mature adipocytes were used. To test the effect of EGCG on viability, cells were incubated for 3, 6, 12, or 24 hours with 0, 50, 100, or 200 microM EGCG. Viability was quantitated by MTS assay. To determine the effect of EGCG on apoptosis, adipocytes were incubated for 24 hours with 0 to 200 microM EGCG, then stained with annexin V and propidium iodide and analyzed by laser scanning cytometry. Both preadipocytes and adipocytes were also analyzed for apoptosis by terminal deoxynucleotidyl transferase dUTP nick-end labeling assay. To determine the effect of EGCG on adipogenesis, maturing preadipocytes were incubated during the 6-day induction period with 0 to 200 microM EGCG, then stained with Oil-Red-O and analyzed for lipid content.

Results: EGCG had no effect on either viability or apoptosis of preconfluent preadipocytes. EGCG also did not affect viability of mature adipocytes; however, EGCG increased apoptosis in mature adipocytes, as demonstrated by both laser scanning cytometry and terminal deoxynucleotidyl transferase dUTP nick-end labeling assays. Furthermore, EGCG dose-dependently inhibited lipid accumulation in maturing preadipocytes.

Discussion: These results demonstrate that EGCG can act directly to inhibit differentiation of preadipocytes and to induce apoptosis of mature adipocytes and, thus, could be an important adjunct in the treatment of obesity.

Citing Articles

Resveratrol and (-)-Epigallocatechin-3-gallate Regulate Lipid Metabolism by Activating the AMPK Pathway in Hepatocytes.

Wang H, An Y, Rajput S, Qi D Biology (Basel). 2024; 13(6).

PMID: 38927248 PMC: 11201192. DOI: 10.3390/biology13060368.


The inhibitory effect of Gremlin-2 on adipogenesis suppresses breast cancer cell growth and metastasis.

Jung J, Kim N, Kwon M, Park J, Lim D, Kim Y Breast Cancer Res. 2023; 25(1):128.

PMID: 37880751 PMC: 10599028. DOI: 10.1186/s13058-023-01732-2.


Management of Obesity-Related Inflammatory and Cardiovascular Diseases by Medicinal Plants: From Traditional Uses to Therapeutic Targets.

Saad B Biomedicines. 2023; 11(8).

PMID: 37626701 PMC: 10452657. DOI: 10.3390/biomedicines11082204.


Natural products as novel anti-obesity agents: insights into mechanisms of action and potential for therapeutic management.

Shaik Mohamed Sayed U, Moshawih S, Goh H, Kifli N, Gupta G, Singh S Front Pharmacol. 2023; 14:1182937.

PMID: 37408757 PMC: 10318930. DOI: 10.3389/fphar.2023.1182937.


The Preventive Mechanisms of Bioactive Food Compounds against Obesity-Induced Inflammation.

Pelczynska M, Moszak M, Wesolek A, Bogdanski P Antioxidants (Basel). 2023; 12(6).

PMID: 37371961 PMC: 10295324. DOI: 10.3390/antiox12061232.